Podcast: Download (Duration: 1:03 — 1.5MB)
Subscribe: RSS
Specially engineered T cells, one component of immune cells in your body, are called CAR-T cells, and for several years now have been used to treat blood cancers and some other conditions, with some success. William Nelson, director of the …
Are CAR-T cells coming into their own as therapeutic agents? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
In trying to discern factors that may account for colorectal cancer incidence in younger people many diet and lifestyle factors fell short, a new study finds. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, points toward insulin …
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
A comprehensive look at lifestyle factors and cancer rates among both older and younger people has left many people scratching their heads. The UK study examined a range of exposures and lifestyle factors trying to elucidate relationships, especially those that …
Podcast: Download (Duration: 1:07 — 1.5MB)
Subscribe: RSS
Daraxonrasib is the name of a drug for pancreas cancer that almost doubled survival for people with the disease in a clinical trial. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says while the drug is going …
A new drug for pancreas cancer may be a game changer, Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
Depending on your media exposure you have likely seen commercials or advertisements for cancer detection tests that look for markers of the disease in your blood. Now a new study examines these tests and determines that they’re really not ready …
